Clinical Trials Directory

Trials / Completed

CompletedNCT01400841

HAART Model 300 Annuloplasty Ring

A Prospective, Non-randomized, Multi-center Trial to Evaluate the Safety and Effectiveness of the HAART Model 300 Annuloplasty Ring When Used to Surgically Repair a Leaking Aortic Valve Using a 3-D Intra-annular Mounting Frame

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Biostable Science & Engineering · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

This investigation is a prospective, non-randomized, multi-center trial to evaluate the safety and effectiveness of the HAART model 300 annuloplasty ring when used to surgically repair a leaking aortic valve using a 3-D intra-annular mounting frame

Detailed description

Aortic Regurgitation, (also known as Aortic Insufficiency; AI), is the failure of the aortic valve to close completely during diastole which causes blood to flow from the aorta back into the left ventricle. Aortic Regurgitation (AR) is a frequent cause of both disability and death due to congestive heart failure, primarily in individuals forty or older, but can also occur in younger populations. Traditionally management of aortic regurgitation has been by aortic valve replacement, however, as has been observed in patients who have had mitral valve repair, the option of maintaining ones native aortic valve versus a replacement, either bioprosthetic or mechanical, can have added multiple benefits. The advantage of repair is the avoidance of prosthetic valve-related complications with bioprosthetic valves over 10-15 years or the need for anticoagulation with mechanical valves and the related problems of this therapy. Therefore, potentially aortic valve repair is a good option for patients with AR or AI.

Conditions

Interventions

TypeNameDescription
DEVICEHAART 300 Annuloplasty DeviceImplantation of device for aortic valve repair

Timeline

Start date
2012-01-01
Primary completion
2013-04-01
Completion
2014-09-01
First posted
2011-07-22
Last updated
2017-01-13
Results posted
2016-11-22

Locations

4 sites across 3 countries: Belgium, Czechia, Germany

Source: ClinicalTrials.gov record NCT01400841. Inclusion in this directory is not an endorsement.